SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Article Pause Article
judgment-img

1992 Supreme(Guj) 128

Gujarat High Court
Judgename :R.K.Abichandani
CIBA GEIGY LIMITED - Appellant
Versus
TORRENT LABORATORIES Private Limited - Respondent
APPELLATE JURISDICTION 1 of 1992
Decided On : 05/06/1992

Advocates Appeared: G.N.SHAH, R.R.SHAH

Headnote:

Trade and Merchandise Marks Act, 1958 – Section 9, 11, 12, 18, 20, 21, 29, 48, 77, 78, 109 – Drugs Control Administration – Medicinal and Pharmaceutical preparations – Respondents No. 1 made an application in accordance with the provisions of Sec. 20 of the Act - Petitioner gave notice of opposition to the registration under Sec. 21 (1) of he Act and respondent No. 1 – Applicant sent its counter-claim in support of his application. Evidence as required by Sec. 21 (4) was submitted in the prescribed manner by the parties – Petitioners contention was that it is carrying on business as manufacturers and merchants of medicines and pharmaceuticals and is a Company incorporated in Switzerland – According to the petitioner, it is Registered proprietor of Trade Mark ciba and several other trade marks incorporating the trade mark ciba which is a part of series of such trade mark ciba was registered under in Class 5 in respect of medicinal preparations pharmaceutical and veterinary preparations, sanitary chemical substances, disinfectants preparations for killing weeds and destroying vermin – According to petitioner ciba forms fore-part and most distinctive and prominent feature of plaintiffs corporate name and trading style – Ciba of India Limited which was predecessor-in-title of Hindustan Ciba-Geigy were recorded registered users of trade mark ciba – Cilia of India limited, after change of its name into Hindustan Ciba-Geigy Limited had extensively used trade mark ciba – According to petitioner, they were Registered Proprietor of Trade Marks ciba, cibazol and cibalgin and other trade marks containing word ciba goods under trademarks cibazol and CIBALGIN were continuously and extensively sold throughout India by Hindustan Ciba-Geigy Limited as registered users/licensees – Petitioner therefore, opposed the use of trade mark ulciban on ground that it was likely to be taken as having some connection with the petitioner because it contains the word ciba which is the most significant part of petitioners name and because ciba is one in a series of trade marks owned by petitioner which contain the word ciba. – According 10 petitioner, their trade mark ciba is distinctive of and is extensively identified with its goods and use of word ciba in the impugned mark ulciban was bound to cause confusion and deception amongst trade and public who would assume that it was yet another mark of the petitioner – Held, In instant case, as held hereinabove, the comparison on whole clearly shows that likelihood of deception or confusion is very strong. It would be noticed from decision of Justice S. H. Sheth in Appeal from rendered that after considering the decision of Supreme Court in Roche and Companys case (supra) and applying the test of visual and phonetic similarity laid down therein in respect of the impugned mark kempisillin and registered trade mark campicillin, upheld the order granting interim injunction on a prima facie finding that these marks were greatly similar to each other and were likely to confuse or deceive their buyers. Even in the decision of this Court in Appeal Order rendered – Court while considering question of grant of interim relief found that there was nothing on record to prima facie show that defendant company had started using the mark carafet to deceive or take advantage of plaintiffs reputation in business – Supreme Court in American Home Products Corporation v. Mac laboratories Pvt. Ltd. and Am. , (reported in AIR 1986 SC 137) held that the intention of the American Company to use the trade mark through the Indian company which was subsequently to get itself registered as the registered user of the said trade mark could not but be characterised as bona fide – This authority in no way supports the petitioner and if at all on the argument of user canvassed by the learned Counsel for the respondent No. 1, it goes against his contention decision has no bearing on the question involved in this matter regarding the prohibition of the registration of a mark under Sec. 11 of Act – On which reliance was placed on behalf of respondent No. 1, Court was considering question of grant of temporary injunction against use of drug under brand name curechlor and trade mark reclor both in respect of medicinal preparations – Court found that two marks were not similar either visually or phonetically and was no instance of Chemist or Customer getting confused while selling or purchasing drugs – It was found that mark curechlor cannot be said to deceptively similar to mark reclor and there was no prima facie case for infringement made out by the plaintiff – Therefore this decision cannot assist respondent – Application is rejected.

ABICHANDANI, J.

( 1 ) THIS is an Appeal under Sec. 109 (2) of the Trade and Merchandise Marks Act, 1958 (hereinafter referred to as the Act) preferred against the decision of the Assistant Registrar of Trade Marks, dated 15th May, 1991 accepting the application of the respondent No. 1 for registration of the trade mark ULCIBAN subject to the amendment under Sec. 18 (4) in the specification of goods so as to read Medicinal and Pharmaceutical preparations containing CIMETIDINE for the treatment of ulcer and to be sold on the written prescription only.

( 2 ) THE respondents No. 1 made an application No. 422819 dated 5th june, 1984 in Class 5 for registration of the trade mark ULCIBAN under sec. 18 (1) of the Act which was advertised in Trade Mark Journal No. 925 dated 16th December, 1989 at Page 678 in accordance with the provisions of Sec. 20 of the Act. The petitioner gave notice of opposition to the registration under Sec. 21 (1) of {he Act and respondent No. 1-Applicant sent its counter-claim in support of his application. Evidence as required by Sec. 21 (4) was submitted in the prescribed manner by the parties. The petitioners contention was that it is carrying on business as manufacturers and merchants of medicines and pharmaceuticals and is a Company incorporated in Switzerland. According to the petitioner, it is the Registered proprietor of Trade Mark ciba and several other trade marks incorporating the trade mark ciba which is a part of the series of such trade marks. The trade mark ciba was registered under No. 1654 dated 2nd July, 1942 in Class 5 in respect of medicinal preparations, pharmaceutical and veterinary preparations, sanitary chemical substances, disinfectants, preparations for killing weeds and destroying vermin. According to the petitioner, ciba forms the fore-part and most distinctive and prominent feature of the plaintiffs corporate name and trading style. Ciba of India Limited, which was the predecessor-in-title of Hindustan Ciba-Geigy were the recorded registered users of the trade mark ciba upto 17th February, 1970. The Cilia of India limited, after the change of its name into Hindustan Ciba-Geigy Limited had extensively used the trade mark ciba. According to the petitioner, they were the Registered Proprietor of Trade Marks ciba, cibazol and cibalgin and other trade marks containing the word ciba. The goods under the trade marks cibazol and CIBALGIN were continuously and extensively sold throughout India by Hindustan Ciba-Geigy Limited as registered users/licensees. The petitioner, there fore, opposed the use of trade mark ulciban on the ground that it was likely to be taken as having some connection with the petitioner because it contains the word ciba which is the most significant part of the petitioners name and because ciba is one in a series of trade marks owned by the petitioner which contain the word ciba. According 10 the- petitioner, their trade mark ciba is distinctive; of and is extensively identified with its goods and use of the word ciba in the impugned mark ulciban was bound to cause confusion and deception amongst the trade and public who would assume that it was yet another mark of the petitioner. According to the petitioner, the goods in the rival mark were identical and the trade channels of the parties were also same. Since the respondent No. 1 was well aware of the petitioners mark at the time of adoption of the impugned mark, adoption was dishonest and with an intention to trade upon the benefit from the reputation and valuable goodwill in the petitioners mark. The petitioner, therefore, took objections under Sees. 9, 11 (a), 11 (e), 12 (1) and 18 (1) of the Act against the registration of the impugned mark.

( 3 ) THE case of the respondent No. 1 was that it had adopted the impugned mark ULCIBAN in the year 1984 and was using the same since then after obtaining the permission from the Drugs Control Administration in the State of Gujarat, In the counter-statement filed by the respo

















Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
whatsapp-icon Back to top